Eyenovia Newsroom

Ladenburg Thalmann Downgrades Eyenovia(EYEN.US) to Hold Rating

Futu NewsNov 19, 2024 16:36

Eyenovia Price Target Cut to $2.00/Share From $12.00 by HC Wainwright & Co.

Dow JonesNov 19, 2024 00:42

William Blair Downgrades Eyenovia(EYEN.US) to Hold Rating

Futu NewsNov 16, 2024 05:31

Eyenovia Analyst Ratings

BenzingaNov 16, 2024 02:20

Brookline Capital Downgrades Eyenovia(EYEN.US) to Hold Rating

Futu NewsNov 15, 2024 22:34

Ladenburg Thalmann Maintains Eyenovia(EYEN.US) With Buy Rating, Cuts Target Price to $4.5

Futu NewsNov 13, 2024 22:32

Eyenovia Analyst Ratings

BenzingaNov 13, 2024 20:34

HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target

BenzingaNov 13, 2024 20:34

Eyenovia's Promising Growth Prospects: Buy Rating Affirmed by Analyst

TipRanksNov 13, 2024 19:39

Eyenovia Analyst Ratings

BenzingaAug 14, 2024 02:20

HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target

BenzingaAug 14, 2024 02:19

Eyenovia's Strategic Collaborations and Innovative Optejet System Underpin Buy Rating

TipRanksAug 13, 2024 18:31

H.C. Wainwright Maintains Eyenovia(EYEN.US) With Buy Rating, Maintains Target Price $12

Futu NewsJul 24, 2024 18:32

HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target

BenzingaJul 24, 2024 18:19

Eyenovia Analyst Ratings

BenzingaJul 24, 2024 18:18

Analysts Offer Insights on Healthcare Companies: Eyenovia (EYEN), Alpine Immune Sciences (ALPN) and GoodRx Holdings (GDRX)

TipRanksMay 16, 2024 20:25

HC Wainwright & Co. : The Eynovia (EYEN.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $12.00.

Zhitong FinanceMay 16, 2024 19:40

Eyenovia Analyst Ratings

BenzingaMay 16, 2024 19:40

HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target

BenzingaMay 16, 2024 19:40

Eyenovia Analyst Ratings

BenzingaMar 19, 2024 19:00